SEC Form 4 · accession 0000899243-18-031205
Solid Biosciences Inc. · SLDB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin I Freed
Director
Period of report
Dec 13, 2018
Accepted (ET)
Dec 17, 2018 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001707502
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $23.58 | Dec 13, 2018 | A | 16,331 | A | — | Dec 13, 2028 | Common Stock | 16,331 | 16,331 | D |
Explanation of responses
- F1This option was granted on December 13, 2018 and vests as to one-third of the total number of shares on each of July 25, 2019, July 25, 2020, and July 25, 2021, and will vest automatically as to 100% of the unvested portion of such option upon specified chage in control events.